Yefan Zhang

897 total citations
33 papers, 396 citations indexed

About

Yefan Zhang is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yefan Zhang has authored 33 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Hepatology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yefan Zhang's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer Mechanisms and Therapy (5 papers). Yefan Zhang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer Mechanisms and Therapy (5 papers). Yefan Zhang collaborates with scholars based in China, United States and Hong Kong. Yefan Zhang's co-authors include Chuanxian Ding, Chen Huang, Zhen Huang, Xinyu Bi, Hong Zhao, Jianqiang Cai, Jianguo Zhou, Jianjun Zhao, Jianqiang Cai and Yue Han and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Yefan Zhang

32 papers receiving 389 citations

Peers

Yefan Zhang
P Schneider United States
M. Rago Italy
Yefan Zhang
Citations per year, relative to Yefan Zhang Yefan Zhang (= 1×) peers Nozomu Sakai

Countries citing papers authored by Yefan Zhang

Since Specialization
Citations

This map shows the geographic impact of Yefan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yefan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yefan Zhang more than expected).

Fields of papers citing papers by Yefan Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yefan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yefan Zhang. The network helps show where Yefan Zhang may publish in the future.

Co-authorship network of co-authors of Yefan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yefan Zhang. A scholar is included among the top collaborators of Yefan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yefan Zhang. Yefan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Zhicheng, Bowen Xu, Jianping Chang, et al.. (2024). MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1. Cancer Cell International. 24(1). 129–129. 1 indexed citations
4.
Wang, Bingchen, Xiaohong Chen, Feng Ye, et al.. (2024). Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis. Frontiers in Immunology. 15. 1491922–1491922.
5.
Bi, Xinyu, Hong Zhao, Guangming Li, et al.. (2024). Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update. Liver Cancer. 14(2). 1–16. 3 indexed citations
6.
Meng, Qinghua, Zhenyu Zhu, Juan Li, et al.. (2023). Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition). Chinese Medical Journal. 136(24). 2909–2911. 1 indexed citations
9.
Xu, Wenjie, Kailun Fei, Yalong Wang, et al.. (2022). Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials. Frontiers in Oncology. 12. 970557–970557. 15 indexed citations
11.
Li, Xingchen, Xinyu Bi, Zhiyu Li, et al.. (2021). A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma. Translational Cancer Research. 10(4). 1773–1786. 5 indexed citations
12.
13.
Luo, Zhiwen, Xiaohong Chen, Yefan Zhang, et al.. (2021). Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy. Frontiers in Cell and Developmental Biology. 8. 577125–577125. 14 indexed citations
14.
Chen, Qichen, Xinyu Bi, Zhiyu Li, et al.. (2021). Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases. Annals of Palliative Medicine. 10(4). 4220–4231. 8 indexed citations
15.
Bi, Xinyu, Yefan Zhang, Jian‐Guo Zhou, et al.. (2021). Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review. HepatoBiliary Surgery and Nutrition. 11(5). 709–717. 13 indexed citations
16.
Luo, Zhiwen, Rui Mao, Hong Zhao, et al.. (2020). Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Advances in Therapy. 37(7). 3185–3205. 4 indexed citations
17.
Li, Jie, Bin Huang, Jiaojiao Zhao, et al.. (2020). A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer. Frontiers in Oncology. 10. 575422–575422. 12 indexed citations
18.
Chen, Xiao, Hong Zhao, Yefan Zhang, et al.. (2019). The safety and feasibility of a single incision in simultaneous resection for patients with colorectal cancer liver metastases. Annals of Translational Medicine. 7(20). 547–547. 2 indexed citations
19.
Zhang, Xinhua, Ye Zhou, Xin Wu, et al.. (2018). Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study. European Journal of Surgical Oncology. 45(3). 318–323. 6 indexed citations
20.
Wang, Jin, Xiaoming Xie, Xi Wang, et al.. (2013). Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: A meta-analysis. Surgical Oncology. 22(4). 247–255. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026